Verition Fund Management 13F: Cuts AMETEK (AME) Stake by $5.7M

Verition Fund Management Reduces Holdings in AMETEK

Verition Fund Management adjusted its portfolio during the reporting period, cutting its stake in AMETEK, Inc. (NYSE:AME) by 33.8%. The filing reveals the fund sold off 23,384 shares of the industrial equipment maker, bringing its total ownership down to 45,797 shares. At the close of the reporting window, that remaining block of stock carried an estimated market value of about $11.13 million. Because 13F filings look backward at portfolio choices made months ago, this report may not reflect the investor's current position today.

AMETEK Stock Context and Market Performance

AMETEK shares recently traded around $242.99, sitting not far from its 50-day moving average of $241.51. The stock has experienced a wide trading range over the past year, stretching from a low of $179.24 up to a high of $261.16. With a trailing price-to-earnings ratio of 35.27, the company trades at a notable valuation compared to many industrial peers. Investors continue to monitor these valuation levels as broader market conditions shift.

Recent Financial Results and Profitability

AMETEK generated $7.86 billion in revenue over the trailing period, delivering a revenue growth rate of 15.0%. The company posted earnings of $6.84 per share alongside a net profit margin of 20.04% and a return on equity of 14.56%. The next earnings report is scheduled for October 29, 2026, which will provide fresh data on revenue growth and profitability metrics.

Dividend Profile for Shareholders

AMETEK pays an annual dividend of $1.36 per share, giving investors a dividend yield of 0.57%. The company's payout ratio sits at a modest 19.01%, meaning it retains the vast majority of its earnings to fund internal growth and operations while still returning a steady cash flow to shareholders.

Analysts Set New Price Targets

Analyst coverage includes several recent updates from major financial firms. On October 12, 2026, Citigroup maintained its neutral rating and set a price target of $263.00. Earlier on October 5, 2026, Baird maintained a neutral rating with a price target of $280.00. BNP Paribas kept an outperform rating on September 11, 2026, raising its target to $290.00. Overall, the stock holds a consensus buy rating with a mean price target of $278.33 based on 18 analyst opinions.

Inside AMETEK's Industrial Operations

AMETEK manufactures and sells electronic instruments and electromechanical devices for customers around the globe. Its operations span specialized sectors including aerospace, defense, medical equipment, and automation technology. The company acts as a key supplier of advanced sensors, precision motion controls, and thermal management systems used across heavy industry and high-tech manufacturing. Institutional investors track these operational segments closely to gauge demand across the industrial economy.

What to Watch at AMETEK, Inc.

As investors digest the latest round of institutional filings, attention turns toward upcoming corporate milestones. The company's next scheduled earnings report on October 29, 2026, will offer fresh insight into how demand holds up across its core operating divisions. Market participants will also want to monitor upcoming institutional filings to see how other large funds adjust their positions in AMETEK shares.